HANDOK Inc. (KRX:002390)
11,950
0.00 (0.00%)
At close: Aug 27, 2025
HANDOK Revenue
HANDOK had revenue of 130.53B KRW in the quarter ending June 30, 2025, with 1.78% growth. This brings the company's revenue in the last twelve months to 500.73B, down -1.98% year-over-year. In the year 2024, HANDOK had annual revenue of 507.36B, down -2.94%.
Revenue (ttm)
500.73B
Revenue Growth
-1.98%
P/S Ratio
0.31
Revenue / Employee
532.70M
Employees
950
Market Cap
153.94B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 507.36B | -15.38B | -2.94% |
Dec 31, 2023 | 522.74B | -21.02B | -3.87% |
Dec 31, 2022 | 543.76B | 26.12B | 5.05% |
Dec 31, 2021 | 517.64B | 14.03B | 2.79% |
Dec 31, 2020 | 503.61B | 30.61B | 6.47% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 5,031.69B |
Celltrion | 3,748.95B |
ALTEOGEN | 158.06B |
Yuhan | 2,165.44B |
SK Biopharmaceuticals | 620.28B |
Peptron | 4.30B |
PharmaResearch | 392.31B |
LigaChem Biosciences | 146.42B |